Internal Medicine, Gastroenterology · Westlake, OH
NPI
1134336662
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
850 Columbia Rd Ste 200
Westlake, OH, 44145
Phone (440) 808-1212
Groups this clinician bills Medicare through
Medicare paid, 2024
$65K
918 services
Medicare patients, 2024
350
Average age 72
Drug cost, 2024
$2.7M
1,405 prescriptions
Company payments, 2025
$642K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Naim Alkhouri was code 99214 (office e&m - established), 326 times for 224 patients. In total Naim Alkhouri billed 918 services in 11 codes, and Medicare paid $65K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 326 | 224 | $89.81 | $29K |
| 76981 Ultrasound - Nonspecific | Office | 255 | 225 | $72.97 | $19K |
| 36415 Venipuncture Blood Collection | Office | 145 | 123 | $7.23 | $1,049 |
| 99213 Office E&M - Established | Office | 73 | 72 | $62.73 | $4,579 |
| 99204 Office E&M - New | Office | 69 | 69 | $110.60 | $7,631 |
| 99215 Office E&M - Established | Office | 18 | 15 | $132.74 | $2,389 |
| 99203 Office E&M - New | Office | 16 | 16 | $64.16 | $1,027 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $12.62 | $151 |
By year: 2022 $50K for 585 services; 2023 $84K for 1,495 services; 2024 $65K for 918 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 145 | 123 | $7.23 | $1,049 |
Medicare prescription drug claims, 2024
In 2024, the drug Naim Alkhouri prescribed most often to Medicare patients was Ursodiol, with 193 prescriptions and refills. In total Naim Alkhouri wrote 1,405 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ursodiol Generic | 193 | 321 | 43 | $195K |
| Spironolactone Generic | 152 | 296 | 48 | $1,528 |
| Furosemide Generic | 136 | 235 | 39 | $487 |
| Xifaxan Rifaximin | 133 | 134 | 26 | $434K |
| Rezdiffra Resmetirom | 98 | 98 | 23 | $381K |
| Carvedilol Generic | 86 | 168 | 27 | $317 |
| Vemlidy Tenofovir Alafenamide | 81 | 89 | Under 11 | $122K |
| Lactulose Generic | 79 | 131 | 27 | $1,614 |
| Prednisone Generic | 40 | 46 | 11 | $277 |
| Epclusa Sofosbuvir/Velpatasvir | 36 | 36 | 13 | $896K |
| Azathioprine Generic | 29 | 63 | Under 11 | $1,057 |
| Tenofovir Disoproxil Fumarate Generic | 26 | 46 | Under 11 | $3,925 |
| Constulose Lactulose | 20 | 24 | Under 11 | $228 |
| Cholestyramine Cholestyramine (With Sugar) | 19 | 25 | Under 11 | $768 |
| Ozempic Semaglutide | 16 | 16 | Under 11 | $15K |
Brand drugs: 508 claims; generic drugs: 897 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naim Alkhouri $642K ($607K in general payments such as food, travel and fees and $35K for research) from 28 companies. The largest payer was Madrigal Pharmaceuticals with $256K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 160 | $256K |
| Novo Nordisk Inc NVO | 43 | $99K |
| Boehringer Ingelheim International GmbH | 44 | $79K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 24 | $58K |
| Sonic Incytes Medical Corp. | 1 | $25K |
| Abbvie Inc. ABBV | 22 | $24K |
| Gilead Sciences, Inc. GILD | 26 | $22K |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $19K |
| Merck Sharp & Dohme LLC MRK | 7 | $15K |
| Novo Nordisk AS NVO | 4 | $11K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.